comparemela.com
  1. Home
  2. Live Updates
  3. Seres Therapeutics (MCRB) Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection : comparemela.com

Seres Therapeutics (MCRB) Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection

Seres Therapeutics (MCRB) Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada ,United States ,Eric Shaff ,Health Science Company ,Seres Therapeutics Inc ,Health Science ,Drug Administration ,Nasdaq ,Biologics License Application ,Chief Medical Officer ,Aimmune Therapeutics ,Chief Executive Officer ,New England Journal ,Infection Protection ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.